These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Correlations between hydroxyprolinuria and kinetic parameters (Ca45) in bone diseases]. Gruson M; Miravet L; Hioco D Ann Biol Clin (Paris); 1967; 25(5):711-24. PubMed ID: 6059730 [No Abstract] [Full Text] [Related]
4. [Calcium-loss-kidney of multiple myeloma and its metabolic consecutive reactions]. Kaiser W; Krosch H; Schmidt GA Z Gesamte Inn Med; 1972 Nov; 27(22):995-9. PubMed ID: 4649663 [No Abstract] [Full Text] [Related]
5. [Hypocalcemia, calcium active hormones and osteocalcin in a case of multiple myeloma]. Pedrazzoni M; Cervellin G; Barbagallo M; Gelmini G; Passeri M Recenti Prog Med; 1985 May; 76(5):260-2. PubMed ID: 3875129 [No Abstract] [Full Text] [Related]
6. [The kinetics of Ca45 in functional alterations of the parathyroid glands]. Conte N; Scandellari C; Federspil G Acta Isot (Padova); 1965 Oct; 5(2):161-71. PubMed ID: 5888043 [No Abstract] [Full Text] [Related]
7. Effect of sodium fluoride therapy on calcium metabolism in multiple myeloma. Neer RM; Zipkin I; Carbone PP; Rosenberg LE J Clin Endocrinol Metab; 1966 Oct; 26(10):1059-68. PubMed ID: 5923687 [No Abstract] [Full Text] [Related]
8. Frequency of calcium binding by monoclonal immunoglobulins in multiple myeloma. Smith BJ; Doukas M; Hess C; Savory J; Wills MR Ann Clin Lab Sci; 1984; 14(4):261-4. PubMed ID: 6465828 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Hungria VT; Latrilha MC; Rodrigues DG; Bydlowski SP; Chiattone CS; Maranhão RC Cancer Chemother Pharmacol; 2004 Jan; 53(1):51-60. PubMed ID: 14574458 [TBL] [Abstract][Full Text] [Related]
10. [Multiple myeloma and the anion gap (author's transl)]. Pigrau Serrallach C; Bosch Gil JA; Durán JR; Pahissa Berga A; Tornos Solano J; Zuazu Nagore FJ Med Clin (Barc); 1981 Oct; 77(6):243-6. PubMed ID: 7321639 [No Abstract] [Full Text] [Related]
11. [Metabolic research with Sr85 in 2 cases of multiple myeloma with pathologic vertebral fractures]. Scoccianti P Arch Putti Chir Organi Mov; 1966; 21():308-15. PubMed ID: 5944464 [No Abstract] [Full Text] [Related]
12. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141 [TBL] [Abstract][Full Text] [Related]
13. [The use of the preparation bonefos in the combined therapy of multiple myeloma patients]. Abdulkadyrov KM; Bessmel'tsev SS Ter Arkh; 1993; 65(12):70-2. PubMed ID: 8146779 [TBL] [Abstract][Full Text] [Related]
14. Hypothalamic digoxin, hemispheric chemical dominance, and oncogenesis: evidence from multiple myeloma. Kurup RK; Kurup PA Int J Neurosci; 2003 Dec; 113(12):1719-40. PubMed ID: 14602544 [TBL] [Abstract][Full Text] [Related]
15. STUDIES OF CALCIUM METABOLISM IN MULTIPLE MYELOMA WITH CALCIUM AND METABOLIC-BALANCE TECHNIQUES. LAZOR MZ; ROSENBERG L; CARBONE P J Clin Invest; 1963 Aug; 42(8):1238-47. PubMed ID: 14057856 [No Abstract] [Full Text] [Related]
16. [Clinicopathological study of multiple myeloma associated with hyperammonemia]. Fujii S; Fukuda S; Sezaki T; Murakami M Rinsho Ketsueki; 1998 Jan; 39(1):27-33. PubMed ID: 9492550 [TBL] [Abstract][Full Text] [Related]